ArticleQuantitative imaging in medicine and surgery2025
Development and validation of a novel echocardiography-based nomogram for the streamlined classification of cardiac tumors in cancer patients.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AI-assisted radiomics for classification of benign and non-benign right heart masses in 2D-echocardiography.Journal of translational medicine · 2026Article
- Multimodal echocardiographic techniques in the diagnosis of cardiac tumors: applications and recent advances.Frontiers in cardiovascular medicine · 2026Review
- Echocardiography Combined With Radiomics and Deep Transfer Learning to Diagnose Hypertrophic Cardiomyopathy and Other Etiologies of Left Ventricular Hypertrophy: A Multicenter Study Comparing the Performance With Echocardiologists.Reviews in cardiovascular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Differentiating cardiac tumors is crucial for treatment planning, but the specificity of echocardiography as a first-line screening tool is limited. This study aimed to develop a streamlined classification model for cardiac tumors in cancer patients using echocardiographic data. Methods: A total of 215 echocardiographic clips representing cardiac tumors from 121 patients with extracardiac malignancies were selected and divided into training and testing cohorts. The cardiac neoplasms were classified as benign or malignant based on substantial evidence. Radiomics features were extracted utilizing PyRadiomics, and a radiomics score (Rad-score) was subsequently computed through an optimized machine learning (ML) framework tailored for tumor classification. Non-experience-dependent indicators (NDIs) derived from baseline and echocardiographic assessments were ascertained and integrated with the Rad-score to construct a classification model. A composite nomogram was developed, and its predictive accuracy was benchmarked against that of junior and senior physicians using receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Results: Significant differences in the Rad-scores and four NDIs [age, tumor location, and long and short diameters (SDs)] (all P<0.05) distinguished benign from malignant tumors. Patients with malignant cardiac tumors were more likely to be younger, for the tumor to be in the right cardiac circulatory system, be larger in size, and have a lower Rad-score. Among these indicators, the Rad-score, tumor location, and SD were shown to be independent predictors of malignancy. The integrated model demonstrated strong classification capability [area under the curve (AUC): 0.873; 95% confidence interval (CI): 0.820-0.914], which was substantiated in the test cohort (AUC: 0.861; 95% CI: 0.807-0.904). The classification performance of the generated nomogram was comparable to that of the senior doctor (AUC: 0.867 Conclusions: This study developed a nomogram that involved radiomics and objective indicators based on echocardiography to effectively distinguish between malignant and benign cardiac tumors, thereby improving classification practices and decision-making in diverse clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.